Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites
Condition(s):Cirrhosis; Ascites HepaticLast Updated:July 13, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Cirrhosis; Ascites HepaticLast Updated:July 13, 2021Completed
Condition(s):Laparoscopic MyomectomyLast Updated:May 2, 2022Recruiting
Condition(s):Hepatectomy, Surgical Blood Loss, TerlipressinLast Updated:December 27, 2017Completed
Condition(s):Liver Cirrhosis; Portal Hypertension; Variceal Hemorrhage; Bleeding; Esophageal and Gastric VaricesLast Updated:February 24, 2023Not yet recruiting
Condition(s):Terlipressin Adverse ReactionLast Updated:July 22, 2019Unknown status
Condition(s):Hemodynamics, Liver, TerlipressinLast Updated:December 19, 2017Completed
Condition(s):MyomaLast Updated:May 2, 2022Recruiting
Condition(s):Acute Kidney Injury; Liver Transplantation; Terlipressin; NGALLast Updated:December 15, 2016Completed
Condition(s):MyomaLast Updated:February 16, 2022Recruiting
Condition(s):Terlipressin Adverse Reaction; Ascites Hepatic; Liver Failure; Acute Kidney InjuryLast Updated:January 9, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.